PD-1 blockade as curative intent therapy in mismatch repair deficient locally advanced rectal cancer

被引：2

作者：

Cercek, Andrea ^{[1
]}

Lumish, Melissa ^{[1
]}

Sinopoli, Jenna ^{[1
]}

Weiss, Jill ^{[1
]}

Shia, Jinru ^{[1
]}

Stadler, Zsofia ^{[1
]}

Yaeger, Rona ^{[1
]}

Smith, J. Joshua ^{[1
]}

Saltz, Leonard ^{[1
]}

Widmar, Maria ^{[1
]}

Crane, Christopher ^{[1
]}

Romesser, Paul ^{[1
]}

Pappou, Emmanouil P. ^{[1
]}

Paty, Philip ^{[1
]}

Garcia-Aguilar, Julio ^{[1
]}

Gonen, Mithat ^{[1
]}

Weiser, Martin ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY USA

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.112

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PS4-2

引用

页码：S1381 / S1381

页数：1

共 50 条

[21] Cure without Surgery and Chemoradiation in locally advanced, Mismatch-repair-deficient Rectal Cancer?
Rink, Andreas D.
Kasper, Stefan
COLOPROCTOLOGY, 2022, 44 (05) : 357 - 360
[22] Neoadjuvant treatment in locally advanced rectal cancer with deficient mismatch repair (dMMR): A paradigm shift
Manuel-Vazquez, Alba
Soria Tristan, Miguel
Martin Martinez, Jose Miguel
Ramos Rodriguez, Jose Luis
CIRUGIA ESPANOLA, 2025, 103 (02): : 118 - 120
[23] Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trial
Yang, Yingchi
Pang, Kai
Lin, Guole
Liu, Xinzhi
Gao, Jiale
Zhou, Jiaolin
Xu, Lai
Gao, Zhidong
Wu, Yingchao
Li, Ang
Han, Jiagang
Wu, Guoju
Wang, Xin
Li, Fei
Ye, Yingjiang
Zhang, Jie
Chen, Guangyong
Wang, Hao
Kong, Yuanyuan
Wu, Aiwen
Xiao, Yi
Yao, Hongwei
Zhang, Zhongtao
NATURE MEDICINE, 2025, 31 (02) : 449 - 456
[24] PD-1 blockade in tumors with mismatch repair deficiency.
Le, Dung T.
Uram, Jennifer N.
Wang, Hao
Bartlett, Bjarne
Kemberling, Holly
Eyring, Aleksandra
Skora, Andrew
Azad, Nilofer Saba
Laheru, Daniel A.
Donehower, Ross C.
Luber, Brandon
Crocenzi, Todd S.
Fisher, George A.
Duffy, Steve M.
Lee, James J.
Koshiji, Minori
Eshleman, James R.
Anders, Robert A.
Vogelstein, Bert
Diaz, Luis A.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[25] PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T.
Uram, J. N.
Wang, H.
Bartlett, B. R.
Kemberling, H.
Eyring, A. D.
Skora, A. D.
Luber, B. S.
Azad, N. S.
Laheru, D.
Biedrzycki, B.
Donehower, R. C.
Zaheer, A.
Fisher, G. A.
Crocenzi, T. S.
Lee, J. J.
Duffy, S. M.
Goldberg, R. M.
de la Chapelle, A.
Koshiji, M.
Bhaijee, F.
Huebner, T.
Hruban, R. H.
Wood, L. D.
Cuka, N.
Pardoll, D. M.
Papadopoulos, N.
Kinzler, K. W.
Zhou, S.
Cornish, T. C.
Taube, J. M.
Anders, R. A.
Eshleman, J. R.
Vogelstein, B.
Diaz, L. A., Jr.
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26): : 2509 - 2520
[26] Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?
Christenson, Eric S.
Meyer, Jeffrey
CURRENT ONCOLOGY REPORTS, 2022, 24 (11) : 1373 - 1375
[27] Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?
Eric S. Christenson
Jeffrey Meyer
Current Oncology Reports, 2022, 24 : 1373 - 1375
[28] Neoadjuvant PD-1 blockade in mismatch repair-deficient or microsatellite instability-high, locally advanced and resectable colorectal cancer: A retrospective real-world analysis.
Lian, Yugui
Su, Chang
Zhao, Ruihua
Lian, Yanbang
Zhou, Quanbo
Jin, Shui-Ling
Guo, Shihao
Sun, Zhenqiang
Zhang, Zhiyong
Wang, Guixian
Fu, Yang
Wang, Yunlong
Yuan, Weitang
Wan, Xiang-Bo
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 185 - 185
[29] PD-1 blockade therapy for cancer
Ribas, Antoni
CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
[30] Neoadjuvant chemoradiotherapy plus PD-1 blockade for high or very high-risk locally advanced rectal cancer
Liu, X.
He, L.
Tong, W.
Li, S.
Wang, Z.
Gu, M.
Li, Y.
Liu, Z.
Chang, P.
Wang, Q.
ANNALS OF ONCOLOGY, 2024, 35 : S108 - S108

← 1 2 3 4 5 →